Stockreport

Oculis to Participate in Upcoming November Investor Conferences

Oculis Holding AG - Ordinary shares  (OCS) 
PDF ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough [Read more]